Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cellebrite DI (CLBT) EBITDA Margin (2020 - 2025)

Cellebrite DI's EBITDA Margin history spans 6 years, with the latest figure at 0.03% for Q4 2025.

  • Quarterly EBITDA Margin changed 0.0% to 0.03% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 9.61% through Dec 2025, down 4764.0% year-over-year, with the annual reading at 0.03% for FY2025, 0.0% changed from the prior year.
  • EBITDA Margin came in at 0.03% for Q4 2025, down from 15.07% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 194.58% in Q3 2024 to a low of 57.66% in Q1 2023.
  • The 5-year median for EBITDA Margin is 11.23% (2022), against an average of 22.77%.
  • Year-over-year, EBITDA Margin skyrocketed 18582bps in 2024 and then crashed -17951bps in 2025.
  • Cellebrite DI's EBITDA Margin stood at 6.34% in 2021, then soared by 74bps to 11.06% in 2022, then surged by 36bps to 15.04% in 2023, then crashed by -100bps to 0.03% in 2024, then rose by 13bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for CLBT's EBITDA Margin are 0.03% (Q4 2025), 15.07% (Q3 2025), and 12.73% (Q2 2025).